UY30307A1 - Moduladores de mglur5 vi - Google Patents
Moduladores de mglur5 viInfo
- Publication number
- UY30307A1 UY30307A1 UY30307A UY30307A UY30307A1 UY 30307 A1 UY30307 A1 UY 30307A1 UY 30307 A UY30307 A UY 30307A UY 30307 A UY30307 A UY 30307A UY 30307 A1 UY30307 A1 UY 30307A1
- Authority
- UY
- Uruguay
- Prior art keywords
- mglur5
- modulators
- therapy
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos novedosos, un proceso para su preparacion, su utilizacion en terapia y composiciones farmacéuticas que los comprenden.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79766406P | 2006-05-05 | 2006-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30307A1 true UY30307A1 (es) | 2007-11-30 |
Family
ID=38603396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30307A UY30307A1 (es) | 2006-05-05 | 2007-04-25 | Moduladores de mglur5 vi |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070259895A1 (es) |
EP (1) | EP2027128A2 (es) |
JP (1) | JP2009536214A (es) |
CN (1) | CN101437825A (es) |
AR (1) | AR060812A1 (es) |
TW (1) | TW200811179A (es) |
UY (1) | UY30307A1 (es) |
WO (1) | WO2007130825A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10160439A1 (de) * | 2001-12-08 | 2003-06-26 | Bosch Gmbh Robert | Laserentfernungsmeßgerät |
US7768422B2 (en) * | 2006-09-06 | 2010-08-03 | Carmen Jr Lawrence R | Method of restoring a remote wireless control device to a known state |
WO2009054789A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
TW200924774A (en) * | 2007-10-26 | 2009-06-16 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mGluR5 |
WO2009054787A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
BRPI0818679A2 (pt) * | 2007-10-26 | 2015-04-14 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, métodos para a inibição dos relaxamentos do sefíncter esofágico inferior transitórios, para o tratamento ou a prenveção da doença do refluxo gastroesfágico, de dor, da ansiedade, e da sídrome do intestino irritável, e, combinação |
WO2009054790A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Amide linked heteroaromatic derivatives as modulators of mglur5 |
WO2009054792A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Aminopyridine derivatives as modulators of mglur5 |
WO2009054786A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
WO2009054785A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole ether derivatives as modulators of mglur5 |
WO2009054793A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
MX2011005982A (es) * | 2008-12-18 | 2011-06-27 | Astrazeneca Ab | Nuevo proceso para preparar 1-[5-(3-clorofenil)isoxazol-3-il]etano na y (r)-1-[5-(3-clorofenil)isoxazol-3-il]etanol. |
ES2443578T3 (es) | 2009-12-29 | 2014-02-19 | Eli Lilly And Company | Compuestos de tetrahidrotriazolopiridina como potenciadores de receptores selectivos de mGlu5 útiles para el tratamiento de la esquizofrenia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6376553B1 (en) * | 1999-03-19 | 2002-04-23 | Knoll Pharmaceutical Company | Treatment of pain |
JP2006502134A (ja) * | 2002-08-09 | 2006-01-19 | アストラゼネカ アクチボラグ | 代謝調節型グルタミン酸受容体において活性を有する化合物 |
JP2006506340A (ja) * | 2002-08-09 | 2006-02-23 | アストラゼネカ アクチボラグ | 代謝調節型グルタミン酸受容体5のモジュレーターとしてのオキサジアゾール |
ES2309718T3 (es) * | 2004-02-18 | 2008-12-16 | Astrazeneca Ab | Compuestos heterociclicos condensados y su uso como antagonistas de los receptores metabotropicos para el tratamiento de trastornos gastrointestinales. |
US7585881B2 (en) * | 2004-02-18 | 2009-09-08 | Astrazeneca Ab | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
CA2556263A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
-
2007
- 2007-04-24 TW TW096114389A patent/TW200811179A/zh unknown
- 2007-04-25 JP JP2009509958A patent/JP2009536214A/ja active Pending
- 2007-04-25 EP EP07797275A patent/EP2027128A2/en not_active Withdrawn
- 2007-04-25 UY UY30307A patent/UY30307A1/es not_active Application Discontinuation
- 2007-04-25 US US11/790,424 patent/US20070259895A1/en not_active Abandoned
- 2007-04-25 CN CNA2007800161463A patent/CN101437825A/zh active Pending
- 2007-04-25 AR ARP070101785A patent/AR060812A1/es unknown
- 2007-04-25 WO PCT/US2007/067372 patent/WO2007130825A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
TW200811179A (en) | 2008-03-01 |
US20070259895A1 (en) | 2007-11-08 |
AR060812A1 (es) | 2008-07-16 |
EP2027128A2 (en) | 2009-02-25 |
CN101437825A (zh) | 2009-05-20 |
WO2007130825A3 (en) | 2008-05-15 |
WO2007130825A2 (en) | 2007-11-15 |
JP2009536214A (ja) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30304A1 (es) | Moduladores de mglur5 i | |
UY30308A1 (es) | Moduladores de mglur5 v | |
UY30307A1 (es) | Moduladores de mglur5 vi | |
UY30306A1 (es) | Moduladores de mglur5 iii | |
UY30305A1 (es) | Moduladores de mglur5 iv | |
UY30309A1 (es) | Moduladores de mglur5 ii | |
CL2008002319A1 (es) | Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. | |
CL2008001815A1 (es) | Compuestos derivados de indazol; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar cancer. | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
BRPI0819218A2 (pt) | Métodos, estojos e composições para administração de compostos farmacêuticos | |
ECSP099495A (es) | Composiciones farmacéuticas y sus métodos de uso | |
CL2007001674A1 (es) | Compuestos derivados de heterociclos, inhibidores de aspartil proteasa; composicion farmaceutica que los comprende;y su uso para tratar enfermedades cardiovasculares,cognitivas y neurodegenerativas. | |
CL2008000873A1 (es) | Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis. | |
ECSP10010245A (es) | Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i | |
CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
CL2011000454A1 (es) | Compuestos derivados de picolinamida, inhibidores de quinasa pim, asociada a tumorigenesis; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. | |
CL2008002430A1 (es) | Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc. | |
CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
CL2008001002A1 (es) | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. | |
CR8717A (es) | Nuevos compuestos | |
CL2008001323A1 (es) | Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. | |
CL2008002076A1 (es) | Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades. | |
CL2008001003A1 (es) | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. | |
UY30610A1 (es) | Moduladores de mglur5 | |
CL2008002041A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170606 |